Research ArticleClinical Studies
Safety and Efficacy of Gemcitabine Plus Cisplatin Against Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective Study
HIROYUKI KODAMA, SHIGENORI KADOWAKI, TAIKO NAKAZAWA, YUKI MATSUBARA, YUKIYA NARITA, KAZUNORI HONDA, TOSHIKI MASUISHI, HIROYA TANIGUCHI, MASASHI ANDO, YUTARO KOIDE, HIROYUKI TACHIBANA, TAKESHI KODAIRA, MICHI SAWABE, HOSHINO TERADA, SHINTARO BEPPU, DAISUKE NISHIKAWA, HIDENORI SUZUKI, NOBUHIRO HANAI and KEI MURO
Anticancer Research March 2024, 44 (3) 1227-1232; DOI: https://doi.org/10.21873/anticanres.16918
HIROYUKI KODAMA
1Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan;
SHIGENORI KADOWAKI
1Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan;
TAIKO NAKAZAWA
1Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan;
YUKI MATSUBARA
1Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan;
YUKIYA NARITA
1Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan;
KAZUNORI HONDA
1Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan;
TOSHIKI MASUISHI
1Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan;
HIROYA TANIGUCHI
1Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan;
MASASHI ANDO
1Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan;
YUTARO KOIDE
2Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Japan;
HIROYUKI TACHIBANA
2Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Japan;
TAKESHI KODAIRA
2Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Japan;
MICHI SAWABE
3Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
HOSHINO TERADA
3Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
SHINTARO BEPPU
3Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
DAISUKE NISHIKAWA
3Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
HIDENORI SUZUKI
3Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
NOBUHIRO HANAI
3Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
KEI MURO
1Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan;
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Safety and Efficacy of Gemcitabine Plus Cisplatin Against Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective Study
HIROYUKI KODAMA, SHIGENORI KADOWAKI, TAIKO NAKAZAWA, YUKI MATSUBARA, YUKIYA NARITA, KAZUNORI HONDA, TOSHIKI MASUISHI, HIROYA TANIGUCHI, MASASHI ANDO, YUTARO KOIDE, HIROYUKI TACHIBANA, TAKESHI KODAIRA, MICHI SAWABE, HOSHINO TERADA, SHINTARO BEPPU, DAISUKE NISHIKAWA, HIDENORI SUZUKI, NOBUHIRO HANAI, KEI MURO
Anticancer Research Mar 2024, 44 (3) 1227-1232; DOI: 10.21873/anticanres.16918
Safety and Efficacy of Gemcitabine Plus Cisplatin Against Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective Study
HIROYUKI KODAMA, SHIGENORI KADOWAKI, TAIKO NAKAZAWA, YUKI MATSUBARA, YUKIYA NARITA, KAZUNORI HONDA, TOSHIKI MASUISHI, HIROYA TANIGUCHI, MASASHI ANDO, YUTARO KOIDE, HIROYUKI TACHIBANA, TAKESHI KODAIRA, MICHI SAWABE, HOSHINO TERADA, SHINTARO BEPPU, DAISUKE NISHIKAWA, HIDENORI SUZUKI, NOBUHIRO HANAI, KEI MURO
Anticancer Research Mar 2024, 44 (3) 1227-1232; DOI: 10.21873/anticanres.16918
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.